Canurta

Business Services · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

2425 Matheson Blvd E Suite 807, Mississa...

Revenue

<$5 Million

Industry

Business Services Research & Development

About Canurta

Canurta Therapeutics specializes in developing multi-target botanical therapies aimed at treating inflammation and neurological diseases through AI-backed discovery and modeling. Their innovative PolyKye platform identifies novel bioactives to guide the selection of compounds and target disease pathways. The company's lead candidate, CNR-401, targets multiple mechanisms involved in conditions like Amyotrophic Lateral Sclerosis (ALS), aiming to slow disease progression and enhance quality of life. Founded in 2019, Canurta combines scientific expertise with technology-driven innovation to accelerate the development of these therapies.Explore more
Canurta's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Canurta Org Chart

PhoneEmail
PK
Canada flag for contact location.

Head of Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Canurta Tech Stack

A closer look at the technologies used by Canurta

Top Business Services Companies

Frequently Asked Questions Regarding Canurta

What is Canurta's official website?
Canurta's official website is www.canurta.com
What is Canurta's Revenue?
Canurta's revenue is <$5 Million
What is Canurta's SIC code?
Canurta's SIC: 87,873
What is Canurta's NAICS code?
Canurta's NAICS: 54,541
How many employees does Canurta have?
Canurta has 11-50 employees
What industry does Canurta belong to?
Canurta is in the industry of: Business Services, Research & Development
What technology does Canurta use?
Some of the popular technologies that Canurta uses are: WordPress.org, reCAPTCHA, Sentry, Microsoft 365
What does Canurta do?

Canurta Therapeutics specializes in developing multi-target botanical therapies aimed at treating inflammation and neurological diseases through AI-backed discovery and modeling. Their innovative PolyKye platform identifies novel bioactives to guide the selection of compounds and target disease pathways. The company's lead candidate, CNR-401, targe... ts multiple mechanisms involved in conditions like Amyotrophic Lateral Sclerosis (ALS), aiming to slow disease progression and enhance quality of life. Founded in 2019, Canurta combines scientific expertise with technology-driven innovation to accelerate the development of these therapies.Read More

What are Canurta social media links?
Canurta Linkedin page
Is Canurta a public company?
Canurta is private company therefore does not currently have an official ticker symbol
See more information about Canurta

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.